We use essential cookies to keep you signed in and remember your course progress. We also use analytics cookies (Umami — privacy-friendly, no personal data) to understand how learners use the platform so we can improve it.
A comprehensive CE course for US private practitioners covering eating disorders, body dysmorphic disorder, psychotropic interactions, mandatory reporting, HIPAA, and holistic patient assessment.
You are viewing
All content reflects US federal and state law — HIPAA · FDA · DEA · NCSBN · ANA · FTC · CMS
US private practitioners in aesthetics and weight management are often the first healthcare professional a patient sees about concerns with a significant mental health component. This course equips you to recognise, respond, and refer safely.
GLP-1 receptor agonists are contraindicated in active anorexia nervosa. Atypical anorexia — at normal BMI — is frequently missed in weight management settings. FDA guidance and APA DSM-5-TR criteria are covered.
Up to 15% of aesthetic clinic patients may have BDD. Prescribing without screening can worsen the condition. This course covers APA DSM-5-TR diagnostic criteria and HIPAA-compliant referral pathways.
US practitioners have mandatory reporting obligations under state law and HIPAA. Knowing when and how to act — including duty to warn and duty to protect — is a legal requirement in all 50 states.
Your duty of care as a private practitioner under US law
Identifying eating disorders in aesthetics and weight management settings
Recognition, screening, and ethical practice in aesthetics
FDA guidance, DEA scheduling, and clinical interaction risks
Your legal obligations under US federal and state law
Protecting mental health information under US federal law
Recognition, screening, and appropriate referral
Recognising and responding to trauma in private practice
Integrating mental health screening into your consultation
Knowing when and how to refer in the US healthcare system
Addressing disparities in mental health and weight management
Protecting your practice under US law
Applying your learning to real-world US clinical scenarios
Educational Disclaimer: Content reflects US federal law (HIPAA, ADA, DEA, FDA) and references ANA, NCSBN, and state mandatory reporting obligations.